This common prescription drug could reduce deaths by sepsis, study finds
Stay up to date with notifications from The Independent
Notifications can be managed in browser preferences.
Critically ill patients with sepsis more likely to survive when given statins
- Research indicates that critically ill sepsis patients who receive statins may have a higher chance of survival.
- A study of 6,000 sepsis patients given statins showed 14.3 per cent died within 28 days, compared to 23.4 per cent of 6,000 patients who did not receive statins, equating to a 39% reduced risk of death.
- The study, conducted using data from a hospital in Israel between 2008 and 2019, also found lower mortality rates in intensive care and overall hospital stays for statin users.
- Dr. Caifeng Li, the study's corresponding author, suggested that statins may offer a protective effect and improve outcomes for sepsis patients.
- Dr. Ron Daniels, founder and chief executive of the UK Sepsis Trust, supports calls for larger trials to confirm the findings, noting the potential survival benefit from the anti-inflammatory properties of statins.